# Uri Kopylov

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/uri-kopylov/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,131 |
| Field | Inflammatory Bowel Disease |
| h-index | 68 |
| i10-index | 201 |
| Last Known Institution | Tel Aviv University |
| OpenAlex ID | https://openalex.org/A5080002704 |
| ORCID iD | https://orcid.org/0000-0002-7156-0588 |
| Works | 539 |

## Researcher papers

Showing 12 of 13.

- [ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications](https://scholariq.org/papers/ecco-esgar-guideline-for-diagnostic-assessment-in-ibd-part-1-initial-diagnosis/)
- [ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-crohn-s-disease-medical-treatment/)
- [ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-crohn-s-disease-surgical-treatment/)
- [ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-ulcerative-colitis-medical-treatment/)
- [ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-ulcerative-colitis-surgical-treatment/)
- [ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease](https://scholariq.org/papers/ecco-guidelines-on-the-prevention-diagnosis-and-management-of-infections-in/)
- [ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects](https://scholariq.org/papers/ecco-esgar-guideline-for-diagnostic-assessment-in-ibd-part-2-ibd-scores-and/)
- [Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial](https://scholariq.org/papers/curcumin-in-combination-with-mesalamine-induces-remission-in-patients-with-mild/)
- [ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-crohn-s-disease-medical-treatment-2/)
- [Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab](https://scholariq.org/papers/levels-of-drug-and-antidrug-antibodies-are-associated-with-outcome-of/)
- [ECCO Guidelines on Inflammatory Bowel Disease and Malignancies](https://scholariq.org/papers/ecco-guidelines-on-inflammatory-bowel-disease-and-malignancies/)
- [Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease](https://scholariq.org/papers/addition-of-an-immunomodulator-to-infliximab-therapy-eliminates-antidrug/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Gastrointestinal Bleeding Diagnosis and Treatment](https://scholariq.org/topics/gastrointestinal-bleeding-diagnosis-and-treatment/)
- [Colorectal Cancer Screening and Detection](https://scholariq.org/topics/colorectal-cancer-screening-and-detection/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)

## Researcher university

- [Tel Aviv University](https://scholariq.org/institutions/tel-aviv-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.